These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7619386)

  • 21. Glucocorticoid-induced skeletal muscle atrophy.
    Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein and amino acid metabolism in uremia: influence of metabolic acidosis.
    Mitch WE; May RC; Maroni BJ; Druml W
    Kidney Int Suppl; 1989 Nov; 27():S205-7. PubMed ID: 2636659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines.
    Mitch WE; Du J; Bailey JL; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):216-9. PubMed ID: 10681642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic acidosis accelerates whole body protein degradation and leucine oxidation by a glucocorticoid-dependent mechanism.
    May RC; Masud T; Logue B; Bailey J; England BK
    Miner Electrolyte Metab; 1992; 18(2-5):245-9. PubMed ID: 1465068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein catabolism in acute renal failure.
    Franz M; Hörl WH
    Miner Electrolyte Metab; 1997; 23(3-6):189-93. PubMed ID: 9387114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease.
    Mitch WE
    Am J Clin Nutr; 1998 Mar; 67(3):359-66. PubMed ID: 9497177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiglucocorticoid RU38486 reduces net protein catabolism in experimental acute renal failure.
    Mondry A
    BMC Nephrol; 2005 Feb; 6():2. PubMed ID: 15715918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.
    Combaret L; Taillandier D; Dardevet D; Béchet D; Rallière C; Claustre A; Grizard J; Attaix D
    Biochem J; 2004 Feb; 378(Pt 1):239-46. PubMed ID: 14636157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of muscle atrophy induced by glucocorticoids.
    Schakman O; Gilson H; Kalista S; Thissen JP
    Horm Res; 2009 Nov; 72 Suppl 1():36-41. PubMed ID: 19940494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of protein turnover in health and disease.
    Newby FD; Price SR
    Miner Electrolyte Metab; 1998; 24(1):6-12. PubMed ID: 9397411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis.
    May RC; Kelly RA; Mitch WE
    J Clin Invest; 1987 Apr; 79(4):1099-103. PubMed ID: 3549778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of muscle wasting associated with chronic kidney disease.
    Workeneh BT; Mitch WE
    Am J Clin Nutr; 2010 Apr; 91(4):1128S-1132S. PubMed ID: 20181807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glucocorticoids and extracellular pH on protein metabolism in cultured cells.
    England BK; Jurkovitz C
    Miner Electrolyte Metab; 1992; 18(2-5):316-9. PubMed ID: 1465082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of metabolic acidosis on amino acid and keto acid metabolism in chronic renal failure].
    Mochizuki T
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):213-24. PubMed ID: 2051649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.
    Bailey JL; Wang X; England BK; Price SR; Ding X; Mitch WE
    J Clin Invest; 1996 Mar; 97(6):1447-53. PubMed ID: 8617877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
    Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
    J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
    Wang X; Hu Z; Hu J; Du J; Mitch WE
    Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure.
    Garibotto G
    Nutrition; 1999 Feb; 15(2):145-55. PubMed ID: 9990580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.